COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?

Title
COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
Authors
Keywords
-
Journal
Multiple Sclerosis and Related Disorders
Volume 42, Issue -, Pages 102120
Publisher
Elsevier BV
Online
2020-04-15
DOI
10.1016/j.msard.2020.102120

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started